Megan Garlapow, PhD

Megan Garlapow is a freelance medical writer who writes about a wide range of medical and scientific topics. She holds a PhD in genetics from North Carolina State University.

Most Recent Articles by Megan Garlapow, PhD

Advanced Renal Cell Carcinoma: Interviews With Neeraj Agarwal, MD, and Ulka Vaishampayan, MD

Advanced Renal Cell Carcinoma: Interviews With Neeraj Agarwal, MD, and Ulka Vaishampayan, MD

By

Ulka Vaishampayan, MD, and Neeraj Agarwal, MD, spoke with Cancer Therapy Advisor about treatment recommendations for patients newly diagnosed with metastatic RCC.

Poorer DLBCL Survival Outcomes Linked to Dual Expression of MYC, BCL2

Poorer DLBCL Survival Outcomes Linked to Dual Expression of MYC, BCL2

By

Dual expression of MYC and BCL2 was associated with worse survival among patients with GCB-like DLBCL, though this status was not associated with any outcomes among patients with ABC-like DLBCL.

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

By

Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.

Immune Checkpoint Inhibitors: Treatment Efficacy in Elderly Patients With Melanoma

Immune Checkpoint Inhibitors: Treatment Efficacy in Elderly Patients With Melanoma

By

Immune checkpoint inhibitors may be effective for treating elderly patients with melanoma without dramatically increasing toxicity.

Hodgkin Lymphoma: Risk-adapted Therapy Recommended

Hodgkin Lymphoma: Risk-adapted Therapy Recommended

By

Long-term follow-up data from randomized trials on Hodgkin lymphoma support current risk-adapted therapeutic approaches for early-stage disease.

More Articles by Megan Garlapow, PhD

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs